US Stock MarketDetailed Quotes

Icecure Medical (ICCM)

Watchlist
  • 0.2298
  • -0.0112-4.65%
Close May 15 16:00 ET
  • 0.2200
  • -0.0098-4.26%
Post 16:36 ET
18.67MMarket Cap-0.96P/E (TTM)

Icecure Medical (ICCM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-16.01%-14.57M
-19.64%-5.02M
14.21%-2.71M
-18.96%-2.81M
-41.62%-4.04M
-0.10%-12.56M
-82.07%-4.2M
5.54%-3.15M
40.49%-2.36M
2.89%-2.85M
Net income from continuing operations
1.70%-15.06M
5.20%-4.25M
6.99%-3.86M
-9.19%-3.36M
0.58%-3.59M
-4.55%-15.32M
-49.55%-4.48M
-3.73%-4.15M
20.78%-3.08M
4.22%-3.61M
Operating gains losses
-392.31%-114K
-3,966.67%-232K
469.57%170K
-361.11%-94K
-2.33%42K
256.00%39K
102.63%6K
-143.81%-46K
-60.00%36K
437.50%43K
Depreciation and amortization
-11.14%295K
-13.41%71K
-12.05%73K
-24.39%62K
4.71%89K
2.79%332K
-1.20%82K
1.22%83K
3.80%82K
7.59%85K
Other non cash items
----
----
---44K
----
----
----
----
----
----
----
Change In working capital
-170.69%-1.07M
-3,886.96%-917K
-79.18%148K
-8.58%405K
-284.11%-707K
189.67%1.52M
-111.92%-23K
336.20%711K
300.45%443K
-1.03%384K
-Change in receivables
6.78%-110K
-180.25%-227K
-90.27%18K
205.95%178K
-46.30%-79K
-372.00%-118K
-1,720.00%-81K
1,750.00%185K
-772.00%-168K
16.92%-54K
-Change in inventory
-321.95%-637K
1,328.57%86K
-3,083.33%-382K
-306.34%-293K
-129.27%-48K
-50.69%287K
-101.89%-7K
-111.43%-12K
-19.77%142K
330.99%164K
-Change in prepaid assets
196.62%229K
119.35%84K
1,196.30%350K
-202.54%-121K
-261.54%-84K
-147.78%-237K
-369.57%-434K
108.54%27K
-57.40%118K
-86.10%52K
-Change in payables and accrued expense
-150.55%-369K
-1,594.12%-288K
-101.81%-10K
462.16%208K
-278.85%-279K
444.34%730K
97.29%-17K
16.14%554K
212.12%37K
637.93%156K
-Change in other current assets
20.66%327K
10.14%76K
16.42%78K
20.00%72K
34.67%101K
48.90%271K
7.81%69K
19.64%67K
328.57%60K
56.25%75K
-Change in other current liabilities
-126.92%-413K
-73.50%-550K
-0.36%277K
50.00%-35K
-43.84%-105K
49.30%-182K
-188.06%-317K
264.50%278K
89.72%-70K
-155.73%-73K
-Change in other working capital
-112.83%-98K
----
----
22.22%396K
-432.81%-213K
641.84%764K
----
----
--324K
--64K
Cash from discontinued investing activities
Operating cash flow
-16.01%-14.57M
-19.64%-5.02M
14.21%-2.71M
-18.96%-2.81M
-41.62%-4.04M
-0.10%-12.56M
-82.07%-4.2M
5.54%-3.15M
40.49%-2.36M
2.89%-2.85M
Investing cash flow
Cash flow from continuing investing activities
-108.07%-36K
71,457.14%5M
-721.49%-5M
97.27%-23K
-101.02%-5K
165.20%446K
-100.08%-7K
-80.94%805K
-156.28%-843K
103.25%491K
Net PPE purchase and sale
49.30%-36K
0.00%-5K
90.63%-3K
-266.67%-22K
78.57%-6K
85.21%-71K
93.83%-5K
58.44%-32K
91.67%-6K
88.80%-28K
Net investment purchase and sale
--0
--5M
-697.37%-5M
--0
--0
205.80%529K
--0
-80.53%837K
-153.31%-837K
103.56%529K
Net other investing changes
----
----
----
----
110.00%1K
-104.05%-12K
---2K
--0
--0
---10K
Cash from discontinued investing activities
Investing cash flow
-108.07%-36K
71,457.14%5M
-721.49%-5M
97.27%-23K
-101.02%-5K
165.20%446K
-100.08%-7K
-80.94%805K
-156.28%-843K
103.25%491K
Financing cash flow
Cash flow from continuing financing activities
72.35%15.83M
237.87%3.72M
122.30%7.47M
10.32%2.09M
-9.69%2.56M
10,968.67%9.19M
1,519.12%1.1M
22,293.33%3.36M
1.89M
2.84M
Net issuance payments of debt
--0
----
----
----
----
--0
----
----
----
----
Net common stock issuance
69.14%15.54M
237.60%3.72M
173.15%9.18M
-95.50%85K
-9.69%2.56M
10,968.67%9.19M
1,226.51%1.1M
--3.36M
--1.89M
--2.84M
Proceeds from stock option exercised by employees
--295K
--3K
----
----
----
--0
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
72.35%15.83M
237.87%3.72M
122.30%7.47M
10.32%2.09M
-9.69%2.56M
10,968.67%9.19M
1,519.12%1.1M
22,293.33%3.36M
--1.89M
--2.84M
Net cash flow
Beginning cash position
-28.19%7.56M
-53.42%4.97M
-44.23%5.38M
-44.92%6.04M
-28.19%7.56M
-55.48%10.53M
178.91%10.67M
218.44%9.65M
96.03%10.97M
-55.48%10.53M
Current changes in cash
141.77%1.22M
219.19%3.7M
-123.84%-241K
43.09%-749K
-411.34%-1.48M
77.72%-2.93M
-147.86%-3.1M
12.33%1.01M
46.79%-1.32M
102.64%476K
Effect of exchange rate changes
379.49%109K
3,933.33%230K
-2,237.50%-171K
4,500.00%92K
2.33%-42K
-256.00%-39K
-102.63%-6K
107.62%8K
102.22%2K
-437.50%-43K
End cash Position
17.62%8.9M
17.62%8.9M
-53.42%4.97M
-44.23%5.38M
-44.92%6.04M
-28.19%7.56M
-28.19%7.56M
178.91%10.67M
218.44%9.65M
96.03%10.97M
Free cash flow
-15.64%-14.61M
-19.62%-5.02M
14.98%-2.71M
-19.59%-2.83M
-40.45%-4.05M
3.04%-12.63M
-76.10%-4.2M
6.73%-3.19M
41.40%-2.37M
9.63%-2.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -16.01%-14.57M-19.64%-5.02M14.21%-2.71M-18.96%-2.81M-41.62%-4.04M-0.10%-12.56M-82.07%-4.2M5.54%-3.15M40.49%-2.36M2.89%-2.85M
Net income from continuing operations 1.70%-15.06M5.20%-4.25M6.99%-3.86M-9.19%-3.36M0.58%-3.59M-4.55%-15.32M-49.55%-4.48M-3.73%-4.15M20.78%-3.08M4.22%-3.61M
Operating gains losses -392.31%-114K-3,966.67%-232K469.57%170K-361.11%-94K-2.33%42K256.00%39K102.63%6K-143.81%-46K-60.00%36K437.50%43K
Depreciation and amortization -11.14%295K-13.41%71K-12.05%73K-24.39%62K4.71%89K2.79%332K-1.20%82K1.22%83K3.80%82K7.59%85K
Other non cash items -----------44K----------------------------
Change In working capital -170.69%-1.07M-3,886.96%-917K-79.18%148K-8.58%405K-284.11%-707K189.67%1.52M-111.92%-23K336.20%711K300.45%443K-1.03%384K
-Change in receivables 6.78%-110K-180.25%-227K-90.27%18K205.95%178K-46.30%-79K-372.00%-118K-1,720.00%-81K1,750.00%185K-772.00%-168K16.92%-54K
-Change in inventory -321.95%-637K1,328.57%86K-3,083.33%-382K-306.34%-293K-129.27%-48K-50.69%287K-101.89%-7K-111.43%-12K-19.77%142K330.99%164K
-Change in prepaid assets 196.62%229K119.35%84K1,196.30%350K-202.54%-121K-261.54%-84K-147.78%-237K-369.57%-434K108.54%27K-57.40%118K-86.10%52K
-Change in payables and accrued expense -150.55%-369K-1,594.12%-288K-101.81%-10K462.16%208K-278.85%-279K444.34%730K97.29%-17K16.14%554K212.12%37K637.93%156K
-Change in other current assets 20.66%327K10.14%76K16.42%78K20.00%72K34.67%101K48.90%271K7.81%69K19.64%67K328.57%60K56.25%75K
-Change in other current liabilities -126.92%-413K-73.50%-550K-0.36%277K50.00%-35K-43.84%-105K49.30%-182K-188.06%-317K264.50%278K89.72%-70K-155.73%-73K
-Change in other working capital -112.83%-98K--------22.22%396K-432.81%-213K641.84%764K----------324K--64K
Cash from discontinued investing activities
Operating cash flow -16.01%-14.57M-19.64%-5.02M14.21%-2.71M-18.96%-2.81M-41.62%-4.04M-0.10%-12.56M-82.07%-4.2M5.54%-3.15M40.49%-2.36M2.89%-2.85M
Investing cash flow
Cash flow from continuing investing activities -108.07%-36K71,457.14%5M-721.49%-5M97.27%-23K-101.02%-5K165.20%446K-100.08%-7K-80.94%805K-156.28%-843K103.25%491K
Net PPE purchase and sale 49.30%-36K0.00%-5K90.63%-3K-266.67%-22K78.57%-6K85.21%-71K93.83%-5K58.44%-32K91.67%-6K88.80%-28K
Net investment purchase and sale --0--5M-697.37%-5M--0--0205.80%529K--0-80.53%837K-153.31%-837K103.56%529K
Net other investing changes ----------------110.00%1K-104.05%-12K---2K--0--0---10K
Cash from discontinued investing activities
Investing cash flow -108.07%-36K71,457.14%5M-721.49%-5M97.27%-23K-101.02%-5K165.20%446K-100.08%-7K-80.94%805K-156.28%-843K103.25%491K
Financing cash flow
Cash flow from continuing financing activities 72.35%15.83M237.87%3.72M122.30%7.47M10.32%2.09M-9.69%2.56M10,968.67%9.19M1,519.12%1.1M22,293.33%3.36M1.89M2.84M
Net issuance payments of debt --0------------------0----------------
Net common stock issuance 69.14%15.54M237.60%3.72M173.15%9.18M-95.50%85K-9.69%2.56M10,968.67%9.19M1,226.51%1.1M--3.36M--1.89M--2.84M
Proceeds from stock option exercised by employees --295K--3K--------------0--0------------
Cash from discontinued financing activities
Financing cash flow 72.35%15.83M237.87%3.72M122.30%7.47M10.32%2.09M-9.69%2.56M10,968.67%9.19M1,519.12%1.1M22,293.33%3.36M--1.89M--2.84M
Net cash flow
Beginning cash position -28.19%7.56M-53.42%4.97M-44.23%5.38M-44.92%6.04M-28.19%7.56M-55.48%10.53M178.91%10.67M218.44%9.65M96.03%10.97M-55.48%10.53M
Current changes in cash 141.77%1.22M219.19%3.7M-123.84%-241K43.09%-749K-411.34%-1.48M77.72%-2.93M-147.86%-3.1M12.33%1.01M46.79%-1.32M102.64%476K
Effect of exchange rate changes 379.49%109K3,933.33%230K-2,237.50%-171K4,500.00%92K2.33%-42K-256.00%-39K-102.63%-6K107.62%8K102.22%2K-437.50%-43K
End cash Position 17.62%8.9M17.62%8.9M-53.42%4.97M-44.23%5.38M-44.92%6.04M-28.19%7.56M-28.19%7.56M178.91%10.67M218.44%9.65M96.03%10.97M
Free cash flow -15.64%-14.61M-19.62%-5.02M14.98%-2.71M-19.59%-2.83M-40.45%-4.05M3.04%-12.63M-76.10%-4.2M6.73%-3.19M41.40%-2.37M9.63%-2.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More